Local Income Levels, Reference Pricing Key To Fix Pricing Of Patented Drugs In India
This article was originally published in PharmAsia News
Executive Summary
A draft circulated by the Department of Pharmaceuticals hopes to provide clarity on pricing of patented drugs in India, but it could lead to heated debate and further complicate pricing strategies for drug makers. The government says it will stick to the core objective to lower health care costs for the masses.